SEARCH WITHIN CONTENT
VOLUME 3 , ISSUE 3 ( July-September, 2021 ) > List of Articles
Rachna Shanbhag, Sagar Bhattad
Keywords : Inflammatory bowel disease, Primary immune deficiency disease, Very early-onset IBD
Citation Information : Shanbhag R, Bhattad S. Is Early-onset Inflammatory Bowel Disease a Primary Immune Deficiency?. Pediatr Inf Dis 2021; 3 (3):125-127.
License: CC BY-NC 4.0
Published Online: 16-09-2021
Copyright Statement: Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.
Pediatric-onset IBDs (PIBDs) are a group of genetically heterogeneous diseases with variable severity. Depending on the age of onset, inflammatory bowel disease (IBD) can be classified as pediatric-onset (<17 years), early-onset (<10 years), very early-onset (<6 years), infant/toddler-onset (0–2 years), and neonatal-onset IBD (<28 days). Due to the advancement of molecular science and sequencing technologies, several monogenic defects have been identified in very early-onset IBD (VEO-IBD) over the last few decades. Inflammatory bowel disease manifesting at a very young age is more likely to be a monogenic defect. Pediatric-onset IBDs have been found to be associated with as many as 60 monogenic defects with most presenting below 6 years of age and some presenting before 1 year of age. The current article discusses early-onset IBD in detail with new concepts and a clinical and laboratory approach to these patients has been provided.
© Jaypee Brothers Medical Publishers (P) LTD.